VIH1.DEVIH1.DEXETRA
Loading
EPS Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change
Year-over-year earnings per share growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P36
Within normal range
Average
24.03%
Historical baseline
| Period | Value |
|---|---|
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 100.00% |
| Q3 2024 | -42.86% |
| Q2 2024 | 0.00% |
| Q1 2024 | -63.92% |
| Q4 2023 | 0.00% |
| Q3 2023 | -51.01% |
| Q2 2023 | 100.00% |
| Q1 2023 | 52.31% |
| Q4 2022 | 96.97% |
| Q3 2022 | -61.18% |
| Q2 2022 | 117.95% |
| Q1 2022 | -89.32% |
| Q4 2021 | 470.31% |
| Q3 2021 | 25.49% |
| Q2 2021 | -15.00% |
| Q1 2021 | -21.05% |
| Q4 2020 | 24.59% |
| Q3 2020 | 3.39% |
| Q2 2020 | 37.21% |
| Q1 2020 | -55.21% |
| Q4 2019 | 113.33% |
| Q3 2019 | -6.25% |
| Q2 2019 | 20.00% |
| Q1 2019 | -47.37% |
| Q4 2018 | 43.40% |
| Q3 2018 | 20.45% |
| Q2 2018 | 22.22% |
| Q1 2018 | -52.63% |
| Q4 2017 | 117.14% |
| Q3 2017 | -10.26% |
| Q2 2017 | 5.41% |
| Q1 2017 | -43.94% |
| Q4 2016 | 73.68% |
| Q3 2016 | 0.00% |
| Q2 2016 | 31.03% |
| Q1 2016 | -42.00% |
| Q4 2015 | 16.28% |
| Q3 2015 | 72.00% |